Act Capital Management, LLC Pds Biotechnology Corp Transaction History
Act Capital Management, LLC
- $72.5 Million
- Q3 2022
A detailed history of Act Capital Management, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Act Capital Management, LLC holds 12,000 shares of PDSB stock, worth $19,200. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,000
Previous 12,000
-0.0%
Holding current value
$19,200
Previous $44,000
18.18%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding PDSB
# of Institutions
54Shares Held
8.16MCall Options Held
151KPut Options Held
1.2K-
Armistice Capital, LLC New York, NY4.42MShares$7.07 Million0.08% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.51MShares$2.42 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$779,1470.0% of portfolio
-
Geode Capital Management, LLC Boston, MA438KShares$700,6090.0% of portfolio
-
Blair William & CO Chicago, IL257KShares$411,5200.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $45.5M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...